Newsmeme!
Discover News you didn't know existed
Rare Lung Diseases
News
Related Video News
No related video news stories found.
Related Videos
No related videos found.
Exome Sequencing Gains Ground as Key Approach for Identifying Genetic Causes of Disease
Published February 9, 2010, 2:15 pm, GenomeWeb News
A host of exome sequencing projects are attempting to demonstrate the technology's utility in identifying the genetic causes of both rare Mendelian diseases as well as more complex diseases, such as heart, lung, and blood diseases.
Required treatment
Published February 9, 2010, 5:03 am, AllAfrica.com
Tukakundana is on the second course of his treatment but will need at least six courses before they can be discharged from hospital. Mr Peter Masiga, 28, from Busia is another parent nursing a three-year-old daughter at the ward.
FDA grants Talecris Biotherapeutics orphan drug designation for Alpha1-Proteinase Inhibitor to treat AAT deficiency
Published February 5, 2010, 9:01 pm, News-Medical-Net
Talecris Biotherapeutics, Inc. announced today that it was granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the development of an aerosol formulation of Alpha1-Proteinase Inhibitor (Human, A1PI) to treat congenital alpha1-antitrypsin (AAT) deficiency. AAT deficiency is a chronic, hereditary condition that increases the risk of certain diseases, especially ...
NHLBI funds preclinical tests on devices for infants and children with congenital heart defects
Published February 4, 2010, 7:36 am, EurekAlert!
( NIH/National Heart, Lung and Blood Institute ) The National Heart, Lung and Blood Institute, part of the National Institutes of Health, has awarded four contracts totaling $23.6 million to begin preclinical testing of devices to help children born with congenital heart defects or those who develop heart failure. The four-year program is called Pumps for Kids, Infants and Neonates.
NHLBI Funds Preclinical Tests on Devices for Infants and Children with Congenital Heart Defects
Published February 4, 2010, 7:20 am, National Institutes of Health
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, has awarded four contracts totaling $23.6 million to begin preclinical testing of devices to help children born with congenital heart defects or those who develop heart failure.
Lung Rx LLC, A Subsidiary Of United Therapeutics Corporation, And mondoBIOTECH holding AG Announce Today a Global ...
Published February 3, 2010, 10:34 am, Business Wire via Yahoo! Finance
SILVER SPRING, Md. & STANS, Switzerland----After completion by mondoBIOTECH of a Phase II study where inhaled Aviptadil was shown to have a unique safety profile and promising signals of long term efficacy over currently approved therapies in patients affected by Pulmonary Arterial Hypertension , United Therapeutics Corporation’s Lung Rx subsidiary and mondoBIOTECH finalized a global strategic ...
Related News Resources:
> HGH News
News Directory
Get started fast by using a pre-defined news directory category
|
Breaking News
and Top Stories |
Business
Earnings, Economy, Personal Finance, and Stock Markets |
Entertainment
Books, Celebrity, Fashion, Movies, Music, Television, and Theatre |
Health
Aging, Diseases, Medical Conditions, Medications, Sexual Health, and Weight Loss |
Politics
Congress, Supreme Court, and White House |
|
Science
Animals, Astronomy, Biotechnology, Space, and Weather |
Sports
Baseball, Basketball, Boxing, Football, Golf, Hockey, Motor Sports, Soccer, and Tennis |
Technology
Communications, Hardware, Internet, Personal Technology, and Software |
United States
and Crimes and Trials |
World
Africa, Antartica, Asia, Australia, Canada, Europe, Latin America, and Middle East |